Biotricity Inc. launched its mobile cardiac monitoring and diagnosis system Bioflux.
The medical device consists of a mobile electrocardiography, or ECG, monitoring device and an ECG viewer software package that enables physicians to remotely monitor and diagnose patients in real time.
Bioflux received 510(k) clearance from the U.S. Food and Drug Administration in December 2017.
